Scynexis (SCYX) Change in Account Payables (2023 - 2026)
Scynexis' (SCYX) quarterly Change in Account Payables came in at $906000.0 in Q1 2026, up 555.28% YoY from $138262.3 in Q1 2025, and up 172.95% on a QoQ basis from -$1.2 million in Q4 2025.
Scynexis (SCYX) Change in Account Payables (2023 - 2026) Analysis & Trends
Scynexis (SCYX) has 4 years of Change in Account Payables data on file, last reported at $906000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 555.28% year-over-year to $906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 75.76% YoY) and the FY2025 annual result came in at -$2.2 million, up 15.7% from the prior year.
- Change in Account Payables advanced to $906000.0 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q4 2023 to a low of -$3.6 million in Q2 2024.
- A 4-year average of -$215846.2 and a median of -$199000.0 in 2025 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 15175.0% in 2024, down 650.0% in 2024.
- Tracing SCYX's Change in Account Payables over 4 years: stood at $3.6 million in 2023, then tumbled by 113.37% to -$484000.0 in 2024, then plunged by 156.61% to -$1.2 million in 2025, then surged by 172.95% to $906000.0 in 2026.
- The last three Change in Account Payables figures came in at $906000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | -472,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -472,000.00 |
| Jun 30, 2026 | -472,000.00 |
| Mar 31, 2026 | 906,000.00 |
| Mar 31, 2026 | 906,000.00 |
| Dec 31, 2025 | -1.24 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | -199,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Jun 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.81 Mn |